Bartlett & Co. Wealth Management »

Candel Therapeutics shares owned by Bartlett & Co. Wealth Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Bartlett & Co. Wealth Management from 13F filings

Historical chart of Bartlett & Co. Wealth Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Bartlett & Co. Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Bartlett & Co. Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $27k 3.5k 7.53

More positions owned by Bartlett & Co. Wealth Management

Alphabet Inc Class C cs (GOOG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard S&P 500 ETF Ex Trd Eq Fd (VOO)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
MasterCard Incorporated (MA)
iShares Core MSCI EAFE ETF Ex Trd Eq Fd (IEFA)
Alphabet Inc Class A cs (GOOGL)
TJX Companies (TJX)
Procter & Gamble Company (PG)
Costco Wholesale Corporation (COST)
Analog Devices (ADI)

View all positions for Bartlett & Co. Wealth Management

Top funds holding Candel Therapeutics

FMR
BlackRock
Portolan Capital Management
Acorn Capital Advisors
Vanguard Capital Management
Vanguard Group
Vestal Point Capital
Millennium Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Sands Capital Ventures
Northern Trust
Vanguard Fiduciary Trust
Vanguard Portfolio Management

View all funds holding Candel Therapeutics